⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RARE News
Ultragenyx Pharmaceutical Inc.
Kuehn Law Encourages Investors of Ultragenyx Pharmaceutical Inc. to Contact Law Firm
prnewswire.com
RARE
Ultragenyx to Participate at Goldman Sachs 47th Annual Global Healthcare Conference
globenewswire.com
RARE
Kuehn Law Encourages Investors of Ultragenyx Pharmaceutical Inc. to Contact Law Firm
globenewswire.com
RARE
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
RARE
Form 8-K
sec.gov
RARE
Amlogenyx Presents Preclinical Data on AM805, a Potentially Transformative Investigational Gene Therapy for Alzheimer’s Disease
globenewswire.com
RARE
Ultragenyx to Participate at Bank of America’s 2026 Healthcare Conference
globenewswire.com
RARE
Form 8-K
sec.gov
RARE
Ultragenyx Reports First Quarter 2026 Financial Results and Corporate Update
globenewswire.com
RARE
Ultragenyx to Host Conference Call for First Quarter 2026 Financial Results and Corporate Update
globenewswire.com
RARE